$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease
October 31, 2019
Click here to read the full article.
Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
October 8, 2019
Click here to read full article.
Gladstone team of (from left) Jae Kyu Ryu, Anke Meyer-Franke, Katerina Akassoglou, and Stephen Freedman worked with entrepreneur Edward Spack to launch MedaRed, Inc.
Meet Gladstone: Andrew Mendiola
June 21, 2019
Andrew is a postdoctoral scholar in Katerina Akassoglou’s lab. He grew up in Marion, Texas, a small town in-between Austin and San Antonio. Before joining Gladstone, he completed a PhD in cellular and molecular biology with a concentration in immunology at The University of Texas at San Antonio.
Click here to read full article.
MS News Today – Need to Know: What Is the Blood Brain Barrier?
June 13, 2019
Click here to read full article.
Sarasota Magazine – Foundation Awards $100,000 Prize for Multiple Sclerosis Research
March 15, 2019
Click here to read full article